Watchlist Price Alert

Hikma Pharmaceuticals (HKMPF)

PNK: HKMPF · Real-Time Price · USD

26.20

-0.36 (-1.36%)

At close: May 01, 2025, 8:00 PM

Hikma Pharmaceuticals Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	Q4 2024	Q2 2024	Q4 2023	Q2 2023	Q4 2022	Q2 2022	Q4 2021	Q2 2021	Q4 2020	Q2 2020	Q4 2019	Q2 2019	Q4 2018	Q2 2018	Q4 2017	Q2 2017	Q4 2016	Q2 2016
Period Ending	Dec 31, 2024	Jun 30, 2024	Dec 31, 2023	Jun 30, 2023	Dec 31, 2022	Jun 30, 2022	Dec 31, 2021	Jun 30, 2021	Dec 31, 2020	Jun 30, 2020	Dec 31, 2019	Jun 30, 2019	Dec 31, 2018	Jun 30, 2018	Dec 31, 2017	Jun 30, 2017	Dec 31, 2016	Jun 30, 2016
Revenue	3.13B	3.02B	2.88B	2.73B	2.52B	2.55B	2.55B	2.42B	2.34B	2.29B	2.21B	2.14B	2.07B	2.02B	1.94B	1.96B	1.95B	1.61B
Cost of Revenue	1.71B	1.57B	1.47B	1.37B	1.25B	1.24B	1.25B	1.17B	1.13B	1.14B	1.11B	1.08B	1.07B	1.06B	1.02B	1.03B	1B	746M
Gross Profit	1.42B	1.45B	1.41B	1.36B	1.26B	1.31B	1.3B	1.25B	1.21B	1.15B	1.1B	1.06B	1B	956M	915M	928M	950M	867M
Operating Income	612M	661M	619M	511M	498M	548M	561M	567M	540M	512M	486M	469M	428M	399M	336M	395M	401M	353M
Interest Income	40M	65M	66M	65M	56M	50M	42M	39M	34M	27M	30M	36M	38M	45M	49M	45M	46M	45M
Pretax Income	455M	367M	281M	220M	233M	440M	544M	603M	558M	539M	491M	378M	293M	-697M	-738M	227M	210M	231M
Net Income	359M	285M	190M	146M	188M	346M	421M	467M	431M	513M	486M	361M	282M	-806M	-843M	166M	155M	176M
Selling & General & Admin	662M	651M	632M	606M	601M	585M	561M	509M	506M	500M	487M	475M	467M	460M	474M	450M	429M	392M
Research & Development	138.54M	146M	149M	139M	144M	153M	143M	134M	137M	140M	150M	156M	147M	121M	121M	156M	150M	73M
Other Expenses	2.46M	64M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Operating Expenses	803M	993M	1.06B	1.07B	976M	818M	715M	610M	621M	586M	578M	646M	673M	1.61B	1.6B	656M	694M	591M
Interest Expense	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	120M	236M	231M	221M	197M
Cost & Expenses	2.52B	2.56B	2.53B	2.45B	2.23B	2.06B	1.97B	1.78B	1.75B	1.73B	1.69B	1.72B	1.74B	2.67B	2.63B	1.69B	1.69B	1.34B
Income Tax Expense	93M	77M	89M	72M	42M	94M	124M	137M	128M	99M	78M	65M	56M	103M	101M	58M	52M	53M
Shares Outstanding (Basic)	221.85M	223.76M	226.45M	222.03M	220.46M	227.93M	233.97M	231.99M	232.87M	243.12M	242.9M	242.15M	241.99M	242.01M	240M	241M	240M	228M
Shares Outstanding (Diluted)	223.04M	223.76M	222.74M	222.03M	221.82M	228M	234M	232M	233M	243M	242.9M	243.1M	241.99M	242.01M	240M	241M	240M	228M
EPS (Basic)	1.61	1.27	0.85	0.66	0.83	1.50	1.81	2.01	1.81	2.11	2.00	1.49	1.17	-3.36	-3.51	0.69	0.65	0.83
EPS (Diluted)	1.61	1.27	0.85	0.66	0.83	1.50	1.81	2.01	1.81	2.11	2.00	1.49	1.17	-3.36	-3.51	0.69	0.65	0.83
EBITDA	787M	844M	791M	730M	670M	768M	718M	653M	654M	616M	584M	566M	527M	514M	461M	508M	506M	441M
EBIT	608M	712M	619M	511M	498M	548M	561M	567M	540M	512M	486M	469M	428M	399M	336M	395M	401M	353M
Depreciation & Amortization	179M	132M	172M	219M	172M	220M	157M	86M	114M	104M	98M	97M	99M	115M	125M	113M	105M	88M